Artificial Intelligence Application in Alzheimer’s Disease

This paper explores the transformative impact of Artificial Intelligence (AI) in Alzheimer's Disease (AD) management through a comprehensive analysis of case studies and literature reviews. Leveraging AI technologies such as machine learning, deep learning, natural language processing (NLP), and generative AI, the paper highlights their potential in addressing long-standing challenges in AD diagnosis, treatment, and care. AI enables proactive disease management, personalized treatments, and improved patient outcomes. Despite promising advancements, challenges such as data privacy, algorithm bias, and interpretability persist. However, the paper identifies best practices to mitigate these challenges, emphasizing transparent algorithm design, standardized protocols, and multidisciplinary collaboration. The implications of AI in AD care extend beyond individual patient outcomes, with potential implications for drug development, precision medicine, and preventive treatments. By fostering trust, addressing ethical considerations, and promoting collaboration, AI-driven solutions have the potential to revolutionize AD research and care, leading to enhanced clinical outcomes and improved quality of life for patients and caregivers. This paper underscores the substantial potential of AI to advance AD research and care, offering valuable insights for future initiatives aimed at addressing the complex challenges posed by this debilitating disease.